CATEQUENTINIB for Neoplasm: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 5 adverse event reports in the FDA FAERS database where CATEQUENTINIB was used for Neoplasm.
Most Reported Side Effects for CATEQUENTINIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Myelosuppression | 84 | 25.9% | 5 | 35 |
| Off label use | 37 | 11.4% | 14 | 6 |
| Diarrhoea | 33 | 10.2% | 4 | 4 |
| Hypertension | 26 | 8.0% | 1 | 2 |
| Nausea | 26 | 8.0% | 3 | 1 |
| Vomiting | 26 | 8.0% | 2 | 1 |
| Rash | 25 | 7.7% | 3 | 3 |
| Thrombocytopenia | 24 | 7.4% | 2 | 0 |
| Fatigue | 23 | 7.1% | 2 | 0 |
| Anaemia | 22 | 6.8% | 3 | 0 |
| Decreased appetite | 22 | 6.8% | 2 | 3 |
| Leukopenia | 21 | 6.5% | 1 | 0 |
| Disease progression | 20 | 6.2% | 3 | 3 |
| Hypothyroidism | 20 | 6.2% | 2 | 3 |
| Neutropenia | 19 | 5.9% | 2 | 1 |
Other Indications for CATEQUENTINIB
Lung neoplasm malignant (41)
Non-small cell lung cancer (24)
Lung adenocarcinoma (20)
Small cell lung cancer extensive stage (19)
Small cell lung cancer (12)
Oesophageal carcinoma (10)
Breast cancer (8)
Breast cancer metastatic (7)
Colorectal cancer metastatic (7)
Lung adenocarcinoma stage iv (7)
Other Drugs Used for Neoplasm
BEVACIZUMAB (502)
ATEZOLIZUMAB (404)
CYCLOPHOSPHAMIDE (385)
CARBOPLATIN (283)
PACLITAXEL (267)
NIVOLUMAB (219)
OXALIPLATIN (185)
PEMBROLIZUMAB (173)
LENALIDOMIDE (171)
DOXORUBICIN (150)